DSM Panel Members Still Getting Pharma Funds
Despite promises to cut back on Pharma funds, 56% of DSM V panel members have reported industry ties— Zero improvement over the percent of DSM-IV members.

Despite promises to cut back on Pharma funds, 56% of DSM V panel members have reported industry ties— Zero improvement over the percent of DSM-IV members.
One of the most controversial proposed disorders for the upcoming revision of psychiatry’s billing bible of mental disorders, (the DSM-5) is Psychosis Risk Syndrome (PRS) a “mental disorder” that, if voted into DSM, would confirm the allegations that psychiatry is manufacturing a Brave New World for itself—heavily backed by Big Pharma—of drugging children before they develop a “mental illness.”
Chad was a Marine Scout Sniper who served two tours in Iraq. Upon being honorably discharged as a Sgt. in 2007, he summoned the courage to ask for help in dealing with the images and emotions that gnawed on him from being dropped into combat.

Ask the average person about the use of electroshock treatment in today’s society and 9 out of 10 will respond, “They still shock people?”

Already, the explosive growth in online advertising has intensified public concerns: the pharmaceutical industry spent more than $1 billion on Internet ads last year and is projected to spend $1.7 billion on such marketing efforts in 2012…
SHARE YOUR STORY/COMMENT: